ADAM10 Expression in Gastric Adenocarcinoma: Results of a Curative Gastrectomy Cohort

Overview

Journal Pak J Med Sci

Specialty General Medicine

Date 2021 Mar 8

PMID 33679947

Citations 2

Authors

Huseyin Alakus

Mustafa Kaya

Hatice Ozer

Hatice Reyhan Egilmez

Kursat Karadayi

Affiliations

Soon will be listed here.

Abstract

Objective: Gastric cancer is among the most common human cancers with high mortality rates. ADAM10, a member of the ADAM (a disintegrin and metalloproteinase) family has also been found to be associated with gastric carcinoma and has been suggested as a potential therapeutic target. Here, we investigated the association of ADAM10 expression with prognosis in gastric adenocarcinoma patients that underwent gastric resection with D2 lymph node dissection.

Methods: Total 86 consecutive patients that underwent resection for gastric adenocarcinoma were included. Immunohistochemical ADAM10 expression and its association with clinicopathological parameters were analyzed. Univariate and multivariate analyses and survival analyses were performed using SPSS ver.22.

Results: High grade tumors, advanced stage tumors and diffuse type tumors showed significantly worse prognosis. A statistically significant association between ADAM10 expression and overall survival (OS) was observed in the univariate analysis, however, this association did not maintain its significance in the multivariate analysis. No statistically significant association was found ADAM-10 expression and clinicopathological parameters.

Conclusion: Immunohistochemical ADAM10 expression may be used as a prognostic marker in gastric adenocarcinoma, however, introduction of a standardized immunohistochemical scoring system seems to be necessary for evaluation of ADAM10 staining.

Citing Articles

Efficacy of the nutritional support team model in the management of patients undergoing total gastrectomy combined with Roux-en-Y anastomosis.

Su W, Yang Y, Wang Q, Zhang W Pak J Med Sci. 2025; 41(1):141-146.

PMID: 39867765 PMC: 11755319. DOI: 10.12669/pjms.41.1.11112.

Efficacy of multimodal analgesia based on the concept of enhanced recovery after surgery in laparoscopic radical gastrectomy for gastric cancer.

Xu L, Yao L, Qin J, Xu H Pak J Med Sci. 2024; 40(10):2190-2195.

PMID: 39554635 PMC: 11568728. DOI: 10.12669/pjms.40.10.10088.

Expression of in Gastric Cancer and its Relation to Tumor Cell Behavior and Prognosis.

Chung M, Park Y, Park S, Joo Y In Vivo. 2022; 36(5):2194-2204.

PMID: 36099146 PMC: 9463901. DOI: 10.21873/invivo.12945.

References

Ghoorun R, Wu X, Chen H, Ren D, Wu X . Prognostic Significance of FKBP14 in Gastric Cancer. Onco Targets Ther. 2020; 12:11567-11577. PMC: 6941606. DOI: 10.2147/OTT.S221943. View

Fang X, Wen J, Sun M, Yuan Y, Xu Q . CircRNAs and its relationship with gastric cancer. J Cancer. 2019; 10(24):6105-6113. PMC: 6856571. DOI: 10.7150/jca.32927. View

Zhang C, Wei S, Hu J, Xiong Z . Upregulated expression of G9a is correlated with poor prognosis of gastric cancer patients. Medicine (Baltimore). 2019; 98(48):e18212. PMC: 6890365. DOI: 10.1097/MD.0000000000018212. View

Li X, Zhu X, Wang Y, Wang R, Wang L, Zhu M . Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer. Oncol Lett. 2019; 18(5):4891-4899. PMC: 6781662. DOI: 10.3892/ol.2019.10820. View

Fang W, Huang K, Chen M, Liu C, Hung Y, Chao Y . Comparative study of the 7th and 8th AJCC editions for gastric cancer patients after curative surgery. PLoS One. 2017; 12(11):e0187626. PMC: 5683565. DOI: 10.1371/journal.pone.0187626. View

Etemad-Moghadam S, Alaeddini M . Upregulation of ADAM10 in oral squamous cell carcinoma and its correlation with EGFR, neoangiogenesis and clinicopathologic factors. J Craniomaxillofac Surg. 2019; 47(10):1583-1588. DOI: 10.1016/j.jcms.2019.07.008. View

Yu J, Lim D, Lee J, Kang W, Park S, Park J . Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (≤45 Years) With Gastric Cancer. Anticancer Res. 2019; 39(10):5811-5820. DOI: 10.21873/anticanres.13785. View

Ge X, Cui H, Zhou Y, Yin D, Feng Y, Xin Q . miR-320a modulates cell growth and chemosensitivity via regulating ADAM10 in gastric cancer. Mol Med Rep. 2017; 16(6):9664-9670. DOI: 10.3892/mmr.2017.7819. View

Yang L, Wang Y, Wang H . Use of immunotherapy in the treatment of gastric cancer. Oncol Lett. 2019; 18(6):5681-5690. PMC: 6865147. DOI: 10.3892/ol.2019.10935. View

10.

Li L, Wang Y, Zhao Z, Ma J . Ezrin is associated with gastric cancer progression and prognosis. Pathol Oncol Res. 2011; 17(4):909-15. DOI: 10.1007/s12253-011-9402-y. View

11.

Bai S, Nasser M, Wang B, Hsu S, Datta J, Kutay H . MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem. 2009; 284(46):32015-27. PMC: 2797273. DOI: 10.1074/jbc.M109.016774. View

12.

Zhou Y, Li Y, Zheng J, Liu K, Zhang H . Detecting of gastric cancer by Bcl-2 and Ki67. Int J Clin Exp Pathol. 2015; 8(6):7287-90. PMC: 4525963. View

13.

Yoshimura T, Tomita T, Dixon M, Axon A, Robinson P, Crabtree J . ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J Infect Dis. 2002; 185(3):332-40. DOI: 10.1086/338191. View

14.

Hu X, Yao J, Gao S, Wang X, Peng X, Yang Y . Nrf2 overexpression predicts prognosis and 5-FU resistance in gastric cancer. Asian Pac J Cancer Prev. 2013; 14(9):5231-5. DOI: 10.7314/apjcp.2013.14.9.5231. View

15.

Knosel T, Emde A, Schluns K, Chen Y, Jurchott K, Krause M . Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia. 2005; 7(8):741-7. PMC: 1501883. DOI: 10.1593/neo.05178. View

16.

Arrington A, Davydova J, Vickers S, Yamamoto M . Anti-ERBB2 sh-RNA suppress both cell growth and tumor growth in ERBB2-overexpressing upper gastrointestinal adenocarcinomas. J Gastrointest Surg. 2009; 13(10):1754-61. PMC: 5093911. DOI: 10.1007/s11605-009-0957-9. View

17.

Ko S, Lin S, Wong Y, Liu C, Chang K, Liu T . Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett. 2005; 245(1-2):33-43. DOI: 10.1016/j.canlet.2005.10.019. View

18.

Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M . Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014; 35(10):9591-5. DOI: 10.1007/s13277-014-2243-z. View

19.

Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T . Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res. 2007; 67(16):7703-12. DOI: 10.1158/0008-5472.CAN-07-0991. View

20.

Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R . ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019; 18(1):156. PMC: 6836474. DOI: 10.1186/s12943-019-1077-0. View